This randomized pilot clinical trial studies how well denosumab works in BRCA1/2 mutations
carriers scheduled for risk-reducing salpingo-oophorectomy. Immunotherapy with denosumab, may
induce changes in body's immune system and may interfere with the ability of tumor cells to
grow and spread.
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Premenopausal